Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.

By C. J. Hu, Liangfang Zhang. Biochemical Pharmacology, 2012

638 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/eeecf451c7d0dac2090879158a20261195f09e8a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. E. Holler
2. J. Ljubimova
3. J. Markman
4. A. Rekechenetskiy

In Molecular Biology

1. E. Holler
2. J. Ljubimova
3. J. Markman
4. A. Rekechenetskiy

Citations in the corpus

• Nanomedicine therapeutic approaches to overcome cancer drug resistance (2013, background): “Further, covalent attachment of hydrophobic drugs such as Doxorubicin and Paclitaxel is frequently employed [6,7,10].”